News Manchester joint venture will trial Morningside's digital he... The University of Manchester has formed a joint venture with Morningside to carry out clinical trials of various digital health technologies developed by the investment group's portfolio co
News Appeal finds NICE must reconsider Alzheimer's drugs Lilly and Eisai's bid to secure NHS coverage of their Alzheimer's therapies has entered a new phase, after an appeal of last year's rejection by NICE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
